Risk Factors for Developing Human Herpesvirus 6 (HHV-6) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation and Its Association with Central Nervous System Disorders

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 1, 2007, Pages 100-106

  Yamane, Akiko ^a   Mori, Takehiko ^a   Suzuki, Shigeaki ^a   Mihara, Ai ^a   Yamazaki, Rie ^a   Aisa, Yoshinobu ^a   Nakazato, Tomonori ^a   Shimizu, Takayuki ^a   Ikeda, Yasuo ^a   Okamoto, Shinichiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Central nervous system disorders; Cord blood transplantation; Hematopoietic stem cell transplantation; Human herpesvirus 6; Polymerase chain reaction

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN G; METHOTREXATE; TACROLIMUS; VIRUS DNA;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; ARTICLE; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HERPES VIRUS INFECTION; HLA MATCHING; HUMAN; HUMAN HERPESVIRUS 6; INCIDENCE; LIVING DONOR; MALE; MULTIVARIATE ANALYSIS; PATIENT MONITORING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDY; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; VIRUS REACTIVATION;

ADULT; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASES; CORD BLOOD STEM CELL TRANSPLANTATION; DNA, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HISTOCOMPATIBILITY TESTING; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; ROSEOLOVIRUS INFECTIONS; VIREMIA;

EID: 33846009094     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.09.003     Document Type: Article

References (31)

1. Bolle L.D., Naesens L., and Erik D.C. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18 (2005) 217-245
2. Clark D.A., and Griffiths P.D. Human herpesvirus 6: relevance of infection in the immunocompromised host (review). Br J Haematol 120 (2003) 384-395
3. Cone R.W., Huang M.W., Ashley R., et al. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol 31 (1993) 1262-1267
4. Yoshikawa T., Asano Y., Ihira M., et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 185 (2002) 847-853
5. Zerr D.M., Meier A.S., Selke S.S., et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352 (2005) 768-776
6. Yoshikawa T., Suzuki K., Ihara M., et al. Prediction of human herpesvirus 6 infection after allogeneic bone marrow transplantation. Blood 92 (1998) 2597-2599
7. Volin L., Lautenschlager I., Juvonen E., et al. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 126 (2004) 690-696
8. Zerr D.M., Corey L., Kim H.W., et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 40 (2005) 932-940
9. Hentrich M., Oruzio D., Jäger G., et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 128 (2004) 66-72
10. Imbert-Marcille B.M., Tang X.W., Lepelletier D., et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 31 (2000) 881-886
11. Cone R.W., Huang M.W., Corey L., et al. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 179 (1999) 311-318
12. Ljungman P., Wang F.Z., Clark D.A., et al. High levels of human herpesvirus 6 DNA in peripheral blood leukocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 111 (2000) 774-781
13. Yoshikawa T., Suga S., Asano Y., et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 78 (1991) 1381-1384
14. Boutolleau D., Fernandez C., André E., et al. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187 (2003) 179-186
15. Chan P.K.S., Peiris J.S.M., Yuen K.Y., et al. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients. J Med Virol 53 (1997) 295-305
16. Ogata M., Kikuchi H., Satou T., et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 193 (2006) 68-79
17. Sashihara J., Tanaka-Taya K., Tanaka S., et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 100 (2002) 2005-2011
18. Tomonari A., Takahashi S., Ooi J., et al. Human herpesvirus 6 variant B infection in adult patients after unrelated cord blood transplantation. Int J Hematol 81 (2005) 352-355
19. Yoshikawa T., Ihara M., Ohashi M., et al. Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 28 (2001) 77-81
20. Cone R.W., Hackman R.C., Huang M.W., et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 329 (1993) 156-161
21. Drobryski W.R., Knox K.K., Majewski D., et al. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow transplant recipient. N Engl J Med 330 (1994) 1356-1360
22. Wang F.Z., Linde A., Hägglund H., et al. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?. Clin Infect Dis 28 (1998) 562-568
23. Cole P.D., Stiles J., Boulad F., et al. Successful treatment of human herpesvirus 6 encephalitis in a bone marrow transplantation recipient. Clin Infect Dis 27 (1998) 653-654
24. Mookerjee B.P., and Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 20 (1997) 905-906
25. Mori T., Okamoto S., Matsuoka S., et al. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 25 (2000) 765-769
26. Mori T., Okamoto S., Watanabe R., et al. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 29 (2002) 777-782
27. Heid C.A., Stevens J., Livak K.J., et al. Real time quantitative PCR. Genome Res 6 (1996) 986-994
28. Maury S., Mary J.Y., Rabian C., et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 115 (2001) 630-641
29. Asano Y., Yoshikawa T., Suga S., et al. Viremia and neutralizing antibody response in infants with exanthema subitum. J Pediatr 114 (1989) 535-539
30. Wilborn F., Brinkmann V., Schmidt C.A., et al. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 83 (1994) 3052-3058
31. Kuhn J.E. Transfusion-associated infections with cytomegalovirus and other human herpesviruses. Infusionsther Transfusionsmed 27 (2000) 138-143